The effect of magnesium supplement on serum fasting glucose and C-reactive protein level in type 2 diabetic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210412001

Enrollment

Registered

2021-04-12

Start date

2020-12-04

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Type 2 No complication Diabetes Type 2

Interventions

Magnesium supplement , Effect to Fasting blood sugar and CRP,Magnesium supplement Effect to Fasting blood sugar and CRP Compare to placebo

Placebo Comparator Dietary Supplement,Active Comparator Dietary Supplement

Magnesium supplement ,Placebo

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Any gender, age 30-65 years old 2. Diagnosed as Type 2 diabetes at least 6 months before 3. Well controlled blood glucose, no plan to adjusted the medicine during experimental 4. FBS 100-250 mg/dl 5. Good conscious and decision 6. Acceptable to thesis method 7. Acceptable following up

Exclusion criteria

Exclusion criteria: 1. Having diabetic complication 2. CKD 3. Using steroid, antiinflammation medicine, herb , other product lowering blood sugar 4. Using diuretic 5. Pregnancy

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose One month Blood sample	—

Secondary

Measure	Time frame
C-reactive protein One months Blood sample	—

Countries

Thailand

Contacts

Public ContactTatcha Takarn

Dhurakij Pundit University

615159100039@dpu.ac.th0622438955

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026